Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.

作者: Eva Karamitopoulou , Svenja Thies , Inti Zlobec , Katja Ott , Marcus Feith

DOI: 10.1097/PAS.0000000000000255

关键词:

摘要: Histopathologic determination of tumor regression provides important prognostic information for locally advanced gastroesophageal carcinomas after neoadjuvant treatment. Regression grading systems mostly refer to the amount therapy-induced fibrosis in relation residual or estimated percentage former site. Although these methods are generally accepted, currently there is no common standard reporting cancers. We compared application 2 major principles assessment regression: hematoxylin and eosin-stained slides from 89 resection specimens esophageal adenocarcinomas following chemotherapy were independently reviewed by 3 pathologists different institutions. Tumor was determined 5-tiered Mandard system (fibrosis/tumor relation) 4-tiered Becker (residual %). Interobserver agreement showed better weighted κ values with (0.78 vs. 0.62). Evaluation whole embedded site improved results (Becker: 0.83; Mandard: 0.73) as only 1 representative slide 0.68; 0.71). Modification into simplified 3-tiered comparable interobserver but stratification both (log rank Becker: P=0.015; P=0.03), independent impact overall survival (modified P=0.011, hazard ratio=3.07; modified P=0.023, ratio=2.72). In conclusion, provide substantial excellent estimation adenocarcinomas. A simple % (complete regression/1% 50% tumor/>50% tumor) maintains highest reproducibility value.

参考文章(24)
Anne-Marie Mandard, Frédéric Dalibard, Jean-Claude Mandard, Jacques Marnay, Michel Henry-Amar, Jean-François Petiot, Alain Roussel, Jacques-Henry Jacob, Philippe Segol, Guy Samama, Jean-Marie Ollivier, Sylvie Bonvalot, Marc Gignoux, Pathologic Assessment of Tumor Regression After Preoperative Chemoradiotherapy of Esophageal Carcinoma. Clinicopathologic Correlations Cancer. ,vol. 73, pp. 2680- 2686 ,(1994) , 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C
Runjan Chetty, Pelvender Gill, Dhirendra Govender, Adrian Bateman, Hee Jin Chang, Vikram Deshpande, David Driman, Marisa Gomez, Godman Greywoode, Eleanor Jaynes, C. Soon Lee, Michael Locketz, Corwyn Rowsell, Anne Rullier, Stefano Serra, Neil Shepherd, Eva Szentgyorgyi, Rajkumar Vajpeyi, Lai Mun Wang, Andrew Bateman, International study group on rectal cancer regression grading : interobserver variability with commonly used regression grading systems Human Pathology. ,vol. 43, pp. 1917- 1923 ,(2012) , 10.1016/J.HUMPATH.2012.01.020
Franz G. Bader, Florian Lordick, Ulrich Fink, Karen Becker, Heinz H&ouml;fler, Raymonde Busch, J&ouml;rg R. Siewert, Katja Ott, Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up. Onkologie. ,vol. 31, pp. 366- 372 ,(2008) , 10.1159/000135515
R. Rosenberg, H. Nekarda, F. Zimmermann, K. Becker, F. Lordick, H. Hofler, M. Molls, J.R. Siewert, Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. Journal of Surgical Oncology. ,vol. 97, pp. 8- 13 ,(2008) , 10.1002/JSO.20844
Andrew P Barbour, Mark Jones, Mithat Gonen, David C Gotley, Janine Thomas, Damien B Thomson, Bryan Burmeister, B Mark Smithers, None, Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response Annals of Surgical Oncology. ,vol. 15, pp. 2894- 2902 ,(2008) , 10.1245/S10434-008-0084-Y
Florian Lordick, Katja Ott, Bernd-Joachim Krause, Wolfgang A Weber, Karen Becker, Hubert J Stein, Sylvie Lorenzen, Tibor Schuster, Hinrich Wieder, Ken Herrmann, Rainer Bredenkamp, Heinz Höfler, Ulrich Fink, Christian Peschel, Markus Schwaiger, Jörg R Siewert, PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncology. ,vol. 8, pp. 797- 805 ,(2007) , 10.1016/S1470-2045(07)70244-9
Fuju Chang, Harriet Deere, Ula Mahadeva, Simi George, Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues. American Journal of Clinical Pathology. ,vol. 129, pp. 252- 262 ,(2008) , 10.1309/CCR3QN4874YJDJJ7
Karen Becker, Rupert Langer, Daniel Reim, Alexander Novotny, Christian Meyer zum Buschenfelde, Jutta Engel, Helmut Friess, Heinz Hofler, Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Annals of Surgery. ,vol. 253, pp. 934- 939 ,(2011) , 10.1097/SLA.0B013E318216F449
T Schmidt, L Sicic, S Blank, K Becker, W Weichert, T Bruckner, T Parakonthun, R Langer, M W Büchler, J-R Siewert, F Lordick, K Ott, Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas. British Journal of Cancer. ,vol. 110, pp. 1712- 1720 ,(2014) , 10.1038/BJC.2014.94
Paul M. Schneider, Stephan E. Baldus, Ralf Metzger, Martin Kocher, Rudolf Bongartz, Elfriede Bollschweiler, Hartmut Schaefer, Juergen Thiele, Hans P. Dienes, Rolf P. Mueller, Arnulf H. Hoelscher, Histomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal Cancer: Implications for Response Classification Annals of Surgery. ,vol. 242, pp. 684- 692 ,(2005) , 10.1097/01.SLA.0000186170.38348.7B